A New Way To Fight Head Lice.
Insecticide-treated underwear won't wipe out lice infestations in dispossessed shelters, according to a additional study. The design initially showed some success, but the lice soon developed resistance to the chemical, the researchers said. Body lice can limits through direct contact and shared clothing and bedding, and the problem is worsened by overcrowded conditions.
Tuesday 21 November 2017
Thursday 16 November 2017
Awareness Against The Global Problem Of Antibiotic Resistance
Awareness Against The Global Problem Of Antibiotic Resistance.
Knowing when to play antibiotics - and when not to - can worker fight the rise of deadly "superbugs," about experts at the US Centers for Disease Control and Prevention. About half of antibiotics prescribed are expendable or inappropriate, the agency says, and overuse has helped create bacteria that don't respond, or rejoin less effectively, to the drugs used to fight them. "Antibiotics are a shared resource that has become a few and far between resource," said Dr Lauri Hicks, a medical epidemiologist at the CDC.
She's also medical manager a of new program, Get Smart: Know When Antibiotics Work, that had its launch this week. "Everyone has a situation to play in preventing the spread of antibiotic resistance". The stakes are high, said Dr Arjun Srinivasan, CDC's affiliated director for health care-associated infection barring programs. Almost every type of bacteria has become stronger and less responsive to antibiotic treatment.
The CDC is urging Americans to use the drugs decently to help prevent the global problem of antibiotic resistance. To that end, the US Food and Drug Administration (FDA), numerous resident medical and controlled associations, as well as state and local health departments have collaborated on the CDC's Get Smart initiative.
Most strains of antibiotic-resistant bacteria are still found in form care settings, such as hospitals and nursing homes. Yet superbugs, including MRSA (methicillin-resistant staphylococcus aureus) - which kills about 19000 Americans a year - are increasingly found in community settings, such as haleness clubs, schools, and workplaces, said Hicks.
Community-associated MRSA (CA-MRSA), a purify that affects nutritious people outside of hospitals, made headlines in 2008, when it killed a Florida costly school football player. Referring to new reports of sinusitis caused by MRSA, Hicks said that "people who would normally be treated with an pronounced antibiotic are requiring more toxic medications or, in some instances, admission to a hospital. We've seen this with pneumonia, too, and I problem we'll start to see it with other types of infections as well".
Knowing when to play antibiotics - and when not to - can worker fight the rise of deadly "superbugs," about experts at the US Centers for Disease Control and Prevention. About half of antibiotics prescribed are expendable or inappropriate, the agency says, and overuse has helped create bacteria that don't respond, or rejoin less effectively, to the drugs used to fight them. "Antibiotics are a shared resource that has become a few and far between resource," said Dr Lauri Hicks, a medical epidemiologist at the CDC.
She's also medical manager a of new program, Get Smart: Know When Antibiotics Work, that had its launch this week. "Everyone has a situation to play in preventing the spread of antibiotic resistance". The stakes are high, said Dr Arjun Srinivasan, CDC's affiliated director for health care-associated infection barring programs. Almost every type of bacteria has become stronger and less responsive to antibiotic treatment.
The CDC is urging Americans to use the drugs decently to help prevent the global problem of antibiotic resistance. To that end, the US Food and Drug Administration (FDA), numerous resident medical and controlled associations, as well as state and local health departments have collaborated on the CDC's Get Smart initiative.
Most strains of antibiotic-resistant bacteria are still found in form care settings, such as hospitals and nursing homes. Yet superbugs, including MRSA (methicillin-resistant staphylococcus aureus) - which kills about 19000 Americans a year - are increasingly found in community settings, such as haleness clubs, schools, and workplaces, said Hicks.
Community-associated MRSA (CA-MRSA), a purify that affects nutritious people outside of hospitals, made headlines in 2008, when it killed a Florida costly school football player. Referring to new reports of sinusitis caused by MRSA, Hicks said that "people who would normally be treated with an pronounced antibiotic are requiring more toxic medications or, in some instances, admission to a hospital. We've seen this with pneumonia, too, and I problem we'll start to see it with other types of infections as well".
Saturday 11 November 2017
Reduced Levels Of Smoking Among Adolescents Has Stopped
Reduced Levels Of Smoking Among Adolescents Has Stopped.
The weakening in the several of US high school students who smoke has slowed significantly, following Thespian drops starting in the late 1990s, according to a new federal report. Twenty percent of consequential school students still smoke, making it impossible to reach the 2010 national goal of reducing cigarette use centre of teens to 16 percent or less, the US Centers for Disease Control and Prevention reported. "The estimate of change started slowing in 2003, and in some groups of students has unqualifiedly stopped and is almost not declining at all," noted lead study author Terry F Pechacek, friend director for science at the CDC's Office on Smoking and Health.
And "The only band in which we are seeing a decline is in African-American females". Part of the problem is that "we have taken our eye off the issue. Sometimes, we get complacent with our good and move on to other things".
Also, states have significantly cut their budgets for tobacco training and cessation programs. And the tobacco industry continues to aggressively target teenagers adding, "The labour has been left with the only voice out there with their $12 billion campaign".
Pechacek said there needs to be renewed stress on getting teens not to smoke. "We've got a new opportunity with the FDA legislation which gives the agency inadvertence over the tobacco industry and the ability it gives the community to do more about restricting advertising, promotion and availability of tobacco products".
That accomplishment needs to be combined with stronger anti-smoking programs, including smoke-free laws and increases in cigarette taxes. "The knack to shut off the inflow of new smokers is critical. The experience that we have had a stall has dramatic implications for the future. Millions of more youth are going to become addicted and one in three of them are accepted to die prematurely".
The weakening in the several of US high school students who smoke has slowed significantly, following Thespian drops starting in the late 1990s, according to a new federal report. Twenty percent of consequential school students still smoke, making it impossible to reach the 2010 national goal of reducing cigarette use centre of teens to 16 percent or less, the US Centers for Disease Control and Prevention reported. "The estimate of change started slowing in 2003, and in some groups of students has unqualifiedly stopped and is almost not declining at all," noted lead study author Terry F Pechacek, friend director for science at the CDC's Office on Smoking and Health.
And "The only band in which we are seeing a decline is in African-American females". Part of the problem is that "we have taken our eye off the issue. Sometimes, we get complacent with our good and move on to other things".
Also, states have significantly cut their budgets for tobacco training and cessation programs. And the tobacco industry continues to aggressively target teenagers adding, "The labour has been left with the only voice out there with their $12 billion campaign".
Pechacek said there needs to be renewed stress on getting teens not to smoke. "We've got a new opportunity with the FDA legislation which gives the agency inadvertence over the tobacco industry and the ability it gives the community to do more about restricting advertising, promotion and availability of tobacco products".
That accomplishment needs to be combined with stronger anti-smoking programs, including smoke-free laws and increases in cigarette taxes. "The knack to shut off the inflow of new smokers is critical. The experience that we have had a stall has dramatic implications for the future. Millions of more youth are going to become addicted and one in three of them are accepted to die prematurely".
Friday 10 November 2017
The Problem Of The Use Of Unproven Dietary Supplements
The Problem Of The Use Of Unproven Dietary Supplements.
US salubrity authorities Wednesday intensified lean on on makers of dietary supplements, caveat individuals or companies marketing "tainted" products that they could face criminal prosecution, among other consequences. The step on it comes after several reports of injury and even death from the use of illegal supplements that are deceptively labeled or restrict undeclared ingredients. These include those laced with the same active ingredients as drugs already approved by the US Food and Drug Administration, analogs (close copies) of those drugs or narrative false steroids that don't qualify as dietary ingredients.
And "Some contain prescription drugs or analogs never tested in humans and the results can be tragic," said Dr Joshua Sharfstein, starring operative commissioner at the FDA, at a Wednesday news conference. "We have received reports of serious adverse events and injuries associated with consumer use of these tainted products, including stroke, liver and kidney damage, pulmonary ruin and death".
Since 2007 FDA has issued alerts on 300 tainted products. "FDA is vocation heed to an important public health problem. Serious injuries have resulted from products masquerading as dietary supplements. They're most often poorly labeled so consumers don't comprehend what they're buying".
Most of the illegal products are marketed in three categories: to call attention to weight loss, to enhance sexual prowess and as body-building products, the agency noted. The weight-loss products identified with problems comprehend Slimming Beauty, Solo Slim and Slim-30, which bear sibutramine (or analogs), the active ingredient in the FDA-approved drug Merida, recently timid from pharmacy shelves due to a heightened risk of heart attack and stroke.
The body-building products number Tren Xtreme, ArimaDex and Clomed, which contain anabolic steroids or aromatase inhibitors, a descent of cancer-fighting drugs that interfere with estrogen production. Consumers should also be aware of "products that present warnings about testing positive in performance drug tests".
US salubrity authorities Wednesday intensified lean on on makers of dietary supplements, caveat individuals or companies marketing "tainted" products that they could face criminal prosecution, among other consequences. The step on it comes after several reports of injury and even death from the use of illegal supplements that are deceptively labeled or restrict undeclared ingredients. These include those laced with the same active ingredients as drugs already approved by the US Food and Drug Administration, analogs (close copies) of those drugs or narrative false steroids that don't qualify as dietary ingredients.
And "Some contain prescription drugs or analogs never tested in humans and the results can be tragic," said Dr Joshua Sharfstein, starring operative commissioner at the FDA, at a Wednesday news conference. "We have received reports of serious adverse events and injuries associated with consumer use of these tainted products, including stroke, liver and kidney damage, pulmonary ruin and death".
Since 2007 FDA has issued alerts on 300 tainted products. "FDA is vocation heed to an important public health problem. Serious injuries have resulted from products masquerading as dietary supplements. They're most often poorly labeled so consumers don't comprehend what they're buying".
Most of the illegal products are marketed in three categories: to call attention to weight loss, to enhance sexual prowess and as body-building products, the agency noted. The weight-loss products identified with problems comprehend Slimming Beauty, Solo Slim and Slim-30, which bear sibutramine (or analogs), the active ingredient in the FDA-approved drug Merida, recently timid from pharmacy shelves due to a heightened risk of heart attack and stroke.
The body-building products number Tren Xtreme, ArimaDex and Clomed, which contain anabolic steroids or aromatase inhibitors, a descent of cancer-fighting drugs that interfere with estrogen production. Consumers should also be aware of "products that present warnings about testing positive in performance drug tests".
Monday 6 November 2017
Both Medications And Deep Brain Stimulation Surgery May Make Better Life With Parkinson'S Disease
Both Medications And Deep Brain Stimulation Surgery May Make Better Life With Parkinson'S Disease.
Parkinson's disability patients do better if they be subjected to heavily brain stimulation surgery in addition to treatment with medication, new research suggests. One year after having the procedure, patients who underwent the surgery reported better blue blood of life and improved facility to get around and engage in routine daily activities compared to those who were treated with medication alone, according to the weigh published in the April 29 online edition of The Lancet Neurology.
The study authors notorious that while the surgery can provide significant benefits for patients, there also is a risk of serious complications. In profoundly brain stimulation, electrical impulses are sent into the brain to adjust areas that control movement, according to credentials information in a news release about the research. In the new study, Dr Adrian Williams of Queen Elizabeth Hospital in Birmingham and colleagues in the United Kingdom randomly assigned 366 Parkinson's ailment patients to either sustain drug treatment or drug treatment extra surgery.
One year later, the patients took surveys about how well they were doing. "Surgery is likely to linger an important treatment option for patients with Parkinson's disease, especially if the way in which deep brain stimulation exerts its medical benefits is better understood, if its use can be optimized by better electrode placement and settings, and if patients who would have the greatest profit can be better identified," the authors concluded.
Deep brain stimulation (DBS) is a surgical procedure in use to treat a variety of disabling neurological symptoms—most commonly the debilitating symptoms of Parkinson's blight (PD), such as tremor, rigidity, stiffness, slowed movement, and walking problems. The operation is also used to treat essential tremor, a common neurological movement disorder.
Parkinson's disability patients do better if they be subjected to heavily brain stimulation surgery in addition to treatment with medication, new research suggests. One year after having the procedure, patients who underwent the surgery reported better blue blood of life and improved facility to get around and engage in routine daily activities compared to those who were treated with medication alone, according to the weigh published in the April 29 online edition of The Lancet Neurology.
The study authors notorious that while the surgery can provide significant benefits for patients, there also is a risk of serious complications. In profoundly brain stimulation, electrical impulses are sent into the brain to adjust areas that control movement, according to credentials information in a news release about the research. In the new study, Dr Adrian Williams of Queen Elizabeth Hospital in Birmingham and colleagues in the United Kingdom randomly assigned 366 Parkinson's ailment patients to either sustain drug treatment or drug treatment extra surgery.
One year later, the patients took surveys about how well they were doing. "Surgery is likely to linger an important treatment option for patients with Parkinson's disease, especially if the way in which deep brain stimulation exerts its medical benefits is better understood, if its use can be optimized by better electrode placement and settings, and if patients who would have the greatest profit can be better identified," the authors concluded.
Deep brain stimulation (DBS) is a surgical procedure in use to treat a variety of disabling neurological symptoms—most commonly the debilitating symptoms of Parkinson's blight (PD), such as tremor, rigidity, stiffness, slowed movement, and walking problems. The operation is also used to treat essential tremor, a common neurological movement disorder.
Wednesday 1 November 2017
Salary Increases In Half For Women Reduces The Risk Of Hypertension By 30 To 35 Percent
Salary Increases In Half For Women Reduces The Risk Of Hypertension By 30 To 35 Percent.
The lowest paid workers are at greater gamble for serious blood press than those taking home bigger paychecks, a strange study suggests. This is particularly true for women and those between 25 and 44 years old, distinguished the researchers from University of California, Davis (UC Davis). The findings could balm reduce the personal and financial costs of high blood pressure, or hypertension, which is a major strength problem, the study authors pointed out in a university news release. "We were surprised that heavy-hearted wages were such a strong risk factor for two populations not typically associated with hypertension, which is more often linked with being older and male," review senior author J Paul Leigh, a professor of noted health sciences at UC Davis, said in the news release.
And "Our outcome shows that women and younger employees working at the lowest return scales should be screened regularly for hypertension as well". Using a public study of families in the United States, which included information on wages, jobs and health, the researchers compiled low-down on over 5600 household heads and their spouses every two years from 1999 to 2005. All of the participants, who ranged from 25 to 65 years of age, were employed. The investigators also excluded anyone diagnosed with steep blood on during the first year of each two-year interval.
The look at found that the workers' wages (annual income divided by work hours) ranged from unkindly $2,38 to $77 per hour in 1999 dollars. During the study, the participants also reported whether or not their poison diagnosed them with high blood pressure. Based on a statistical analysis, the researchers found that doubling a person's undertake was associated with a 16 percent drop in their risk for hypertension.
The lowest paid workers are at greater gamble for serious blood press than those taking home bigger paychecks, a strange study suggests. This is particularly true for women and those between 25 and 44 years old, distinguished the researchers from University of California, Davis (UC Davis). The findings could balm reduce the personal and financial costs of high blood pressure, or hypertension, which is a major strength problem, the study authors pointed out in a university news release. "We were surprised that heavy-hearted wages were such a strong risk factor for two populations not typically associated with hypertension, which is more often linked with being older and male," review senior author J Paul Leigh, a professor of noted health sciences at UC Davis, said in the news release.
And "Our outcome shows that women and younger employees working at the lowest return scales should be screened regularly for hypertension as well". Using a public study of families in the United States, which included information on wages, jobs and health, the researchers compiled low-down on over 5600 household heads and their spouses every two years from 1999 to 2005. All of the participants, who ranged from 25 to 65 years of age, were employed. The investigators also excluded anyone diagnosed with steep blood on during the first year of each two-year interval.
The look at found that the workers' wages (annual income divided by work hours) ranged from unkindly $2,38 to $77 per hour in 1999 dollars. During the study, the participants also reported whether or not their poison diagnosed them with high blood pressure. Based on a statistical analysis, the researchers found that doubling a person's undertake was associated with a 16 percent drop in their risk for hypertension.
Monday 23 October 2017
Relationship Between Immune System And Mental Illness
Relationship Between Immune System And Mental Illness.
In the prime precise illustration of exactly how some psychiatric illnesses might be linked to an immune system gone awry, researchers story they cured mice of an obsessive-compulsive condition known as "hair-pulling disorder" by tweaking the rodents' insusceptible systems. Although scientists have noticed a link between the immune system and psychiatric illnesses, this is the win evidence of a cause-and-effect relationship, said the authors of a study appearing in the May 28 progeny of the journal Cell. The "cure" in this case was a bone marrow transplant, which replaced a simple gene with a normal one.
The excitement lies in the fact that this could open the way to new treatments for other mental disorders, although bone marrow transplants, which can be life-threatening in themselves, are not a likely candidate, at least not at this point. "There are some drugs already existing that are serviceable with respect to immune disorders," said think over senior author Mario Capecchi, the recipient of a 2007 Nobel Prize in physiology or medicine. "This is very redesigned information in terms of there being some kind of immune reaction in the body that could be contributing to mental robustness symptoms," said Jacqueline Phillips-Sabol, an assistant professor of neurosurgery and psychiatry at Texas A&M Health Science Center College of Medicine and chairman of the neuropsychology division at Scott & White in Temple, Texas. "This helps us remain to unravel the mystery of mental illness, which utilized to be shrouded in mysticism. We didn't know where it came from or what caused it".
However, Phillips-Sabol was intelligent to point out that bone marrow transplants are not a reasonable treatment for mental health disorders. "That's to all intents and purposes a stretch at least at this point. Most patients who have obsessive-compulsive disorder (OCD) are fairly successfully treated with psychotherapy. The recounting starts with a mouse mutant that has a very unusual behavior, which is very nearly the same to the obsessive-compulsive spectrum disorder in humans called trichotillomania, when patients compulsively remove all their body hair," explained Capecchi, who is a noted professor of human genetics and biology at the University of Utah School of Medicine and an investigator with the Howard Hughes Medical Institute.
Some 2 percent to 3 percent of mortals worldwide take from the disorder. The same group of researchers had earlier discovered the case for the odd behavior: these mice had changes in a gene known as Hoxb8. To their great surprise, the gene turns out to be affected in the development of microglia, a type of immune cell found in the brain but originating in the bone marrow, whose known job is to clean up damage in the brain.
In the prime precise illustration of exactly how some psychiatric illnesses might be linked to an immune system gone awry, researchers story they cured mice of an obsessive-compulsive condition known as "hair-pulling disorder" by tweaking the rodents' insusceptible systems. Although scientists have noticed a link between the immune system and psychiatric illnesses, this is the win evidence of a cause-and-effect relationship, said the authors of a study appearing in the May 28 progeny of the journal Cell. The "cure" in this case was a bone marrow transplant, which replaced a simple gene with a normal one.
The excitement lies in the fact that this could open the way to new treatments for other mental disorders, although bone marrow transplants, which can be life-threatening in themselves, are not a likely candidate, at least not at this point. "There are some drugs already existing that are serviceable with respect to immune disorders," said think over senior author Mario Capecchi, the recipient of a 2007 Nobel Prize in physiology or medicine. "This is very redesigned information in terms of there being some kind of immune reaction in the body that could be contributing to mental robustness symptoms," said Jacqueline Phillips-Sabol, an assistant professor of neurosurgery and psychiatry at Texas A&M Health Science Center College of Medicine and chairman of the neuropsychology division at Scott & White in Temple, Texas. "This helps us remain to unravel the mystery of mental illness, which utilized to be shrouded in mysticism. We didn't know where it came from or what caused it".
However, Phillips-Sabol was intelligent to point out that bone marrow transplants are not a reasonable treatment for mental health disorders. "That's to all intents and purposes a stretch at least at this point. Most patients who have obsessive-compulsive disorder (OCD) are fairly successfully treated with psychotherapy. The recounting starts with a mouse mutant that has a very unusual behavior, which is very nearly the same to the obsessive-compulsive spectrum disorder in humans called trichotillomania, when patients compulsively remove all their body hair," explained Capecchi, who is a noted professor of human genetics and biology at the University of Utah School of Medicine and an investigator with the Howard Hughes Medical Institute.
Some 2 percent to 3 percent of mortals worldwide take from the disorder. The same group of researchers had earlier discovered the case for the odd behavior: these mice had changes in a gene known as Hoxb8. To their great surprise, the gene turns out to be affected in the development of microglia, a type of immune cell found in the brain but originating in the bone marrow, whose known job is to clean up damage in the brain.
Friday 20 October 2017
The Number Of People With Dementia Increases
The Number Of People With Dementia Increases.
The tons of hoi polloi worldwide living with dementia could more than triple by 2050, a new report reveals. Currently, an estimated 44 million males and females worldwide have dementia. That number is expected to go as far as 76 million in 2030 and 135 million by 2050. Those estimates come from an Alzheimer's Disease International (ADI) procedure brief for the upcoming G8 Dementia Summit in London, England.
The projected thousand of people with dementia in 2050 is now 17 percent higher than ADI estimated in the 2009 World Alzheimer Report. The further policy brief also predicts a swerve in the worldwide distribution of dementia cases, from the richest nations to middle- and low-income countries. By 2050, 71 percent of men and women with dementia will live in middle- and low-income nations, according to the experts.
The tons of hoi polloi worldwide living with dementia could more than triple by 2050, a new report reveals. Currently, an estimated 44 million males and females worldwide have dementia. That number is expected to go as far as 76 million in 2030 and 135 million by 2050. Those estimates come from an Alzheimer's Disease International (ADI) procedure brief for the upcoming G8 Dementia Summit in London, England.
The projected thousand of people with dementia in 2050 is now 17 percent higher than ADI estimated in the 2009 World Alzheimer Report. The further policy brief also predicts a swerve in the worldwide distribution of dementia cases, from the richest nations to middle- and low-income countries. By 2050, 71 percent of men and women with dementia will live in middle- and low-income nations, according to the experts.
Wednesday 18 October 2017
New Blood Thinners Are Effective In Combination With Low Doses Of Aspirin
New Blood Thinners Are Effective In Combination With Low Doses Of Aspirin.
Brilinta, an tentative anti-clotting medication currently awaiting US Food and Drug Administration approval, performed better than the production standard, Plavix, when cast-off in tandem with low-dose aspirin, a reborn study finds. Heart patients who took Brilinta (ticagrelor) with low-dose aspirin (less than 300 milligrams) had fewer cardiovascular complications than those taking Plavix (clopidogrel) extra low-dose aspirin, researchers found.
However, patients who took Brilinta with higher doses of aspirin (more than 300 milligrams) had worse outcomes than those who took Plavix increased by high-dose aspirin, the investigators reported. Antiplatelet drugs are old to delay potentially dangerous blood clots from forming in patients with grave coronary syndrome, including those who have had a heart attack. Brilinta has already been approved for use in many other countries.
In July 2010, an FDA panel voted 7-to-1 to ratify the use of Brilinta for US patients undergoing angioplasty or stenting to unpromised blocked arteries, but the approval modify is still ongoing. The panel's recommendation was based in part on prior findings from this study, called the Platelet Inhibition and Patient Outcomes (PLATO) trial.
Brilinta, an tentative anti-clotting medication currently awaiting US Food and Drug Administration approval, performed better than the production standard, Plavix, when cast-off in tandem with low-dose aspirin, a reborn study finds. Heart patients who took Brilinta (ticagrelor) with low-dose aspirin (less than 300 milligrams) had fewer cardiovascular complications than those taking Plavix (clopidogrel) extra low-dose aspirin, researchers found.
However, patients who took Brilinta with higher doses of aspirin (more than 300 milligrams) had worse outcomes than those who took Plavix increased by high-dose aspirin, the investigators reported. Antiplatelet drugs are old to delay potentially dangerous blood clots from forming in patients with grave coronary syndrome, including those who have had a heart attack. Brilinta has already been approved for use in many other countries.
In July 2010, an FDA panel voted 7-to-1 to ratify the use of Brilinta for US patients undergoing angioplasty or stenting to unpromised blocked arteries, but the approval modify is still ongoing. The panel's recommendation was based in part on prior findings from this study, called the Platelet Inhibition and Patient Outcomes (PLATO) trial.
Thursday 5 October 2017
Statins May Reduce The Risk Of Prostate Cancer
Statins May Reduce The Risk Of Prostate Cancer.
Cholesterol-lowering statins significantly mark down prostate tumor inflammation, which may hand lower the risk of disease progression, redesigned study findings suggest. Duke University Medical Center researchers found that the use of statins before prostate cancer surgery was associated with a 69 percent reduced good chance of inflammation preferential prostate tumors.
For the study, the researchers examined tissue samples of prostate tumors from 236 men undergoing prostate cancer surgery. The patients included 37 who took statins during the year erstwhile to their surgery.
Overall, 82 percent of the men had riotous cells in their prostate tumors and about one-third had signal tumor inflammation. After they accounted for factors such as age, mill-race and body-mass index (a measurement that is based on weight and height), the Duke team concluded that statin use was associated with reduced swelling within tumors.
Cholesterol-lowering statins significantly mark down prostate tumor inflammation, which may hand lower the risk of disease progression, redesigned study findings suggest. Duke University Medical Center researchers found that the use of statins before prostate cancer surgery was associated with a 69 percent reduced good chance of inflammation preferential prostate tumors.
For the study, the researchers examined tissue samples of prostate tumors from 236 men undergoing prostate cancer surgery. The patients included 37 who took statins during the year erstwhile to their surgery.
Overall, 82 percent of the men had riotous cells in their prostate tumors and about one-third had signal tumor inflammation. After they accounted for factors such as age, mill-race and body-mass index (a measurement that is based on weight and height), the Duke team concluded that statin use was associated with reduced swelling within tumors.
Subscribe to:
Posts (Atom)